Your browser doesn't support javascript.
loading
Gene therapy with apoptosis-associated speck-like protein, a newly described schwannoma tumor suppressor, inhibits schwannoma growth in vivo.
Ahmed, Sherif G; Abdelnabi, Ahmed; Maguire, Casey A; Doha, Mohamed; Sagers, Jessica E; Lewis, Rebecca M; Muzikansky, Alona; Giovannini, Marco; Stemmer-Rachamimov, Anat; Stankovic, Konstantina M; Fulci, Giulia; Brenner, Gary J.
Afiliación
  • Ahmed SG; Department of Anesthesiology, Critical Care, and Pain Medicine, Massachusetts General Hospital (MGH), Harvard Medical School, Boston, Massachusetts.
  • Abdelnabi A; Department of Anesthesiology, Critical Care, and Pain Medicine, Massachusetts General Hospital (MGH), Harvard Medical School, Boston, Massachusetts.
  • Maguire CA; Department of Neurology, Massachusetts General Hospital, and NeuroDiscovery Center, Harvard Medical School, Boston, Massachusetts.
  • Doha M; Department of Anesthesiology, Critical Care, and Pain Medicine, Massachusetts General Hospital (MGH), Harvard Medical School, Boston, Massachusetts.
  • Sagers JE; Eaton Peabody Laboratories and Department of Otolaryngology, Massachusetts Eye and Ear and Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts.
  • Lewis RM; Harvard Program in Speech and Hearing Bioscience and Technology, Boston, Massachusetts.
  • Muzikansky A; Eaton Peabody Laboratories and Department of Otolaryngology, Massachusetts Eye and Ear and Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts.
  • Giovannini M; Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Stemmer-Rachamimov A; Department of Head and Neck Surgery, David Geffen School of Medicine at UCLA and Jonsson Comprehensive Cancer Center (JCCC), University of California, Los Angeles, California.
  • Stankovic KM; Molecular Pathology Division, Massachusetts General Hospital, Boston, Massachusetts.
  • Fulci G; Eaton Peabody Laboratories and Department of Otolaryngology, Massachusetts Eye and Ear and Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts.
  • Brenner GJ; Harvard Program in Speech and Hearing Bioscience and Technology, Boston, Massachusetts.
Neuro Oncol ; 21(7): 854-866, 2019 07 11.
Article en En | MEDLINE | ID: mdl-30977509
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Genética / Biomarcadores de Tumor / Apoptosis / Proteínas Adaptadoras de Señalización CARD / Dolor en Cáncer / Neurilemoma Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans / Male Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Genética / Biomarcadores de Tumor / Apoptosis / Proteínas Adaptadoras de Señalización CARD / Dolor en Cáncer / Neurilemoma Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans / Male Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido